Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000825495 | SCV000966798 | uncertain significance | not specified | 2018-09-12 | criteria provided, single submitter | clinical testing | The p.Cys3016Tyr variant in USH2A has not been previously reported in individual s with hearing loss or Usher syndrome, but has been identified in 0.07% (13/1884 4) of East Asian chromosomes by gnomAD (http://gnomad.broadinstitute.org). Compu tational prediction tools and conservation analysis suggest that this variant ma y not impact the protein, though this information is not predictive enough to ru le out pathogenicity. In summary, the clinical significance of the p.Cys3016Tyr variant is uncertain. ACMG/AMP Criteria applied: BP4. |
Labcorp Genetics |
RCV001038198 | SCV001201659 | likely benign | not provided | 2024-01-05 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001273707 | SCV001457077 | uncertain significance | Usher syndrome type 2A | 2020-09-16 | no assertion criteria provided | clinical testing |